NCT05677048 Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention Status ACTIVE_NOT_RECRUITING Phase NA
NCT05675059 Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT05663515 A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs Status RECRUITING Phase N/A
NCT05660915 A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy Status RECRUITING Phase NA
NCT05657743 A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer Status RECRUITING Phase NA
NCT05642962 Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05638269 A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China Status RECRUITING Phase N/A
NCT05632328 AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05631574 Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer Status TERMINATED Phase PHASE1
NCT05617872 Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound Status COMPLETED Phase NA
NCT05616494 A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer Status UNKNOWN Phase PHASE2
NCT05604573 DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer Status UNKNOWN Phase N/A
NCT05604560 A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05600933 Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment Status ENROLLING_BY_INVITATION Phase N/A